Similarly, toll like receptor 4 (TLR4) mutation or oral antibiotics protected against high fructose diet-induced NAFLD in mice [17,25], highlighting the importance of the gut-liver axis in the pathogenesis of dietary fructose associated NAFLD and metabolic syndrome. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.